The scientist’s investigation covers issues in Surgery, Radiation therapy, Glioma, Brachytherapy and Pathology. The concepts of his Surgery study are interwoven with issues in Anaplastic astrocytoma, Internal medicine and Oncology. Particularly relevant to Radiosurgery is his body of work in Radiation therapy.
His Glioma research integrates issues from Blood flow, Blood oxygenation level dependent and Premovement neuronal activity. His Brachytherapy study incorporates themes from Survival rate, Survival analysis and Craniotomy. The study incorporates disciplines such as Animal model, Central nervous system and In vivo in addition to Pathology.
His primary scientific interests are in Surgery, Radiation therapy, Nuclear medicine, Radiology and Glioma. His Surgery research focuses on Internal medicine and how it connects with Procarbazine. His Radiation therapy study combines topics in areas such as Anaplastic astrocytoma, Chemotherapy and Oncology.
His research in Oncology intersects with topics in Bevacizumab and Temozolomide. His study in Nuclear medicine is interdisciplinary in nature, drawing from both Radiation treatment planning, Magnetic resonance imaging, Irradiation and Meningioma. His Glioma research is multidisciplinary, incorporating perspectives in Brain tumor and Pathology.
Philip H. Gutin spends much of his time researching Surgery, Radiology, Radiation therapy, Glioma and Internal medicine. Philip H. Gutin has included themes like Malignancy and Cohort in his Surgery study. The Radiology study combines topics in areas such as Cancer and Nuclear medicine.
His Radiation therapy research is multidisciplinary, incorporating elements of In vivo magnetic resonance spectroscopy, Progression-free survival, High-Grade Glioma and Medical imaging. His work carried out in the field of Glioma brings together such families of science as Neurosurgery, Preoperative care and Surgical planning. His Internal medicine study frequently draws connections to adjacent fields such as Oncology.
Philip H. Gutin focuses on Surgery, Glioma, Cancer research, Radiation therapy and Magnetic resonance imaging. His biological study spans a wide range of topics, including Internal medicine, Clinical trial, Radiology and Histopathology. His work on Improved survival, Multiple cancer, Immunotherapy and Immune checkpoint inhibitors as part of general Internal medicine research is frequently linked to Text mining, thereby connecting diverse disciplines of science.
His Glioma research includes themes of Neurosurgery, Pathology, Metabolite and Intraoperative MRI. His Radiation therapy research includes elements of Time to recurrence, Resection and Medical record. His Imaging biomarker study, which is part of a larger body of work in Magnetic resonance imaging, is frequently linked to Mitotic index, bridging the gap between disciplines.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Tumor mutational load predicts survival after immunotherapy across multiple cancer types.
Robert M Samstein;Chung-Han Lee;Chung-Han Lee;Alexander N Shoushtari;Alexander N Shoushtari;Matthew D Hellmann;Matthew D Hellmann.
Nature Genetics (2019)
NovoTTF-100A versus physician’s choice chemotherapy in recurrent glioblastoma: A randomised phase III trial of a novel treatment modality
Roger Stupp;Eric T. Wong;Andrew A. Kanner;David Steinberg.
European Journal of Cancer (2012)
Genomic Analysis of Non-NF2 Meningiomas Reveals Mutations in TRAF7, KLF4, AKT1, and SMO
Victoria E. Clark;E. Zeynep Erson-Omay;Akdes Serin;Jun Yin.
Radiosurgery for brain metastases: is whole brain radiotherapy necessary?
Penny K Sneed;Kathleen R Lamborn;Julie M Forstner;Michael W McDermott.
International Journal of Radiation Oncology Biology Physics (1999)
Superiority of post-radiotherapy adjuvant chemotherapy with CCNU, procarbazine, and vincristine (PCV) over BCNU for anaplastic gliomas: NCOG 6G61 final report.
Victor A. Levin;Pamela Silver;John Hannigan;William M. Wara.
International Journal of Radiation Oncology Biology Physics (1990)
Survival benefit of hyperthermia in a prospective randomized trial of brachytherapy boost +/- hyperthermia for glioblastoma multiforme.
Penny K. Sneed;Paul R. Stauffer;Michael W. McDermott;Chris J. Diederich.
International Journal of Radiation Oncology Biology Physics (1996)
Parthenogenetic stem cells in nonhuman primates
Jose B. Cibelli;Kathleen A. Grant;Karen B. Chapman;Kerrianne Cunniff.
Intergeneric poliovirus recombinants for the treatment of malignant glioma
Matthias Gromeier;Sylvie Lachmann;Myrna R. Rosenfeld;Philip H. Gutin.
Proceedings of the National Academy of Sciences of the United States of America (2000)
Survival and Functional Status after Resection of Recurrent Glioblastoma Multiforme
Fred G. Barker;Susan M. Chang;Philip H. Gutin;Mary K. Malec.
Radiation therapy in the treatment of partially resected meningiomas.
Nicholas M. Barbaro;Philip H. Gutin;Charles B. Wilson;Glenn E. Sheline.
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: